Literature DB >> 1138403

Hemorrhagic infarction: A reperfusion injury following prolonged myocardial ischemic anoxia.

F B Cerra, T Z Lajos, M Montes, J H Siegel.   

Abstract

Sixteen canine myocardial pedicle preparations were divided into four groups. Group I received 60 minutes of reversible ischemic anoxia, Group II 90 minutes, Group III 120 minutes, and Group IV 180 minutes. Transmural ischemic infarction was present in Group I. With longer periods of anoxia, capillary disruption occurred, first in the subendocardium (90 minutes) and then transmurally (180 minutes). Reperfusion after ischemic, anoxic time periods of 90 minutes or greater produced hemorrhagic necrosis, the extent of which was directly proportional to the duration of the preceding ischemic, anoxic period. One hundred and twenty patients with aortic valve replacement surgery then were analyzed retrospectively. Of the 25 deaths, seven were due to immediate postinfarction, five from subendocardial hemorrhagic necrosis. The common factor in the patients with hemorrhagic infarction was a markedly reduced coronary flow (45 to 55 ml. per minute) for more than 70 minutes during the interval of cardiopulmonary bypass. Although other factors may be involved, it is hypothesized that the main cause is a degree of localized ischemia of sufficient duration to induce capillary disruption and subsequent postbypass hemorrhagic necrosis when normal coronary artery perfusion is resumed.

Entities:  

Mesh:

Year:  1975        PMID: 1138403

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

Review 1.  How sound is the evidence that thrombolysis increases the risk of cardiac rupture?

Authors:  D R Massel
Journal:  Br Heart J       Date:  1993-04

2.  The influence of reperfusin on infarct size after experimental coronary artery occlusion.

Authors:  M Hofmann; M Hofmann; K Genth; W Schaper
Journal:  Basic Res Cardiol       Date:  1980 Jul-Aug       Impact factor: 17.165

3.  Mitochondrial damage during myocardial ischemia.

Authors:  V Regitz; D J Paulson; R J Hodach; S E Little; W Schaper; A L Shug
Journal:  Basic Res Cardiol       Date:  1984 Mar-Apr       Impact factor: 17.165

4.  Venous drainage, a simple method to prevent the systemic consequences of ischaemia-reperfusion injury in acute lower limb ischaemia.

Authors:  D N Coakley; T Moloney; J McCormick; F M Shaikh; P A Grace
Journal:  Ir J Med Sci       Date:  2010-03       Impact factor: 1.568

Review 5.  Lymphocytes and ischemia-reperfusion injury.

Authors:  Douglas Linfert; Tayseer Chowdhry; Hamid Rabb
Journal:  Transplant Rev (Orlando)       Date:  2009-01       Impact factor: 3.943

Review 6.  Role of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heart.

Authors:  Vimal Agrawal; Jeetendra Kumar Gupta; Shaiba Sana Qureshi; Vishal Kumar Vishwakarma
Journal:  Indian Heart J       Date:  2016-08-29

7.  Thrombospondin-1/CD47 blockade following ischemia-reperfusion injury is tissue protective.

Authors:  Justin B Maxhimer; Hubert B Shih; Jeffrey S Isenberg; Thomas W Miller; David D Roberts
Journal:  Plast Reconstr Surg       Date:  2009-12       Impact factor: 5.169

Review 8.  The paradigm of postconditioning to protect the heart.

Authors:  C Penna; D Mancardi; S Raimondo; S Geuna; P Pagliaro
Journal:  J Cell Mol Med       Date:  2007-12-20       Impact factor: 5.310

9.  Early risk prognosis of free-flap transplant failure by quantitation of the macrophage colony-stimulating factor in patient plasma using 2-dimensional liquid-chromatography multiple reaction monitoring-mass spectrometry.

Authors:  Jingzhi Yang; Juliane C Finke; Juncong Yang; Andrew J Percy; Uwe von Fritschen; Christoph H Borchers; Michael O Glocker
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

10.  A Conformational Change in C-Reactive Protein Enhances Leukocyte Recruitment and Reactive Oxygen Species Generation in Ischemia/Reperfusion Injury.

Authors:  Jan R Thiele; Johannes Zeller; Jurij Kiefer; David Braig; Sheena Kreuzaler; Yvonne Lenz; Lawrence A Potempa; Florian Grahammer; Tobias B Huber; M Huber-Lang; Holger Bannasch; G Björn Stark; Karlheinz Peter; Steffen U Eisenhardt
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.